Melanotan II Side Effects: Complete Research Guide

Melanotan II is an analog of alpha-melanocyte-stimulating hormone (α-MSH) that activates melanocortin receptors MC1R through MC5R. MC1R activation drives melanogenesis (tanning), while MC4R activation in the brain produces effects on sexual arousal and appetite. This broad receptor activity explains both its desired effects and its side effects.

The most frequently reported side effects of Melanotan II include:

• Nausea: Very common, especially with initial doses. Often managed by starting at low doses (0.1-0.25 mg) and using antihistamines.
• Facial flushing: Temporary redness and warmth, typically lasting 30-60 minutes post-injection.
• Appetite suppression: Can be significant in some users.
• Drowsiness and fatigue: Often reported in the hours following injection.
• Spontaneous erections: Common in males, particularly at higher doses.

One of the most important safety considerations with MT-2 is its effect on existing moles and nevi. Because it stimulates melanocytes broadly, it can darken existing moles, create new freckles, and potentially make it harder to detect changes associated with melanoma. Researchers should:

• Document all moles with photos before starting
• Monitor for asymmetry, border irregularity, color changes, and diameter growth (ABCD criteria)
• Get regular dermatological screenings
• Discontinue use if any mole shows concerning changes

Starting with a very low dose (0.1 mg) and gradually increasing to 0.25-0.5 mg allows tolerance to build for nausea. Injecting before bedtime helps sleep through the nausea and flushing. Using an antihistamine 30 minutes prior can also reduce nausea. Maintenance dosing of 0.5 mg once or twice weekly can sustain a tan with reduced side effects.

Source research-grade MT-2 from trusted suppliers like Ascension Peptides to ensure purity and minimize contamination-related reactions.